Angiotensin (1-7): Mechanism, Evidence & Precision Research Use

Executive Summary: Angiotensin (1-7) (Asp-Arg-Val-Tyr-Ile-His-Pro) is an endogenous heptapeptide hormone derived from angiotensin I or II by specific peptidases, acting primarily as a Mas receptor agonist and counterbalancing classical renin–angiotensin system (RAS) effects (Oliveira et al., 2025). Its signaling modulates PI3K/AKT and ERK pathways, influencing nitric oxide, FOXO1, and COX-2, with downstream anti-fibrotic and anti-inflammatory outcomes. Experimental data show roles in metabolic regulation, cerebroprotection, and inhibition of cancer cell proliferation. APExBIO's Angiotensin (1-7) (SKU A1041) offers high-purity, reproducible material for these studies (APExBIO). Practical workflows and application boundaries are clarified for research reproducibility and translational relevance.

Biological Rationale

Angiotensin (1-7) is a heptapeptide hormone with the amino acid sequence Asp-Arg-Val-Tyr-Ile-His-Pro, produced endogenously by enzymatic cleavage of angiotensin I or II (Oliveira et al., 2025). Unlike angiotensin II, which is associated with vasoconstriction and fibrosis, Ang-(1-7) exerts vasodilatory, anti-inflammatory, and anti-fibrotic effects by activating the Mas receptor, a G protein-coupled receptor. The renin–angiotensin system (RAS) is central to cardiovascular, renal, and metabolic homeostasis. Angiotensin (1-7) is a key counter-regulatory mediator within this system, opposing the pathological actions of angiotensin II, particularly in heart, kidney, and vascular tissues. This distinct functional profile underpins its increasing utility in both basic and translational research (see detailed workflow analysis—this article extends that by mapping precise mechanistic links to experimental endpoints).

Mechanism of Action of Angiotensin (1-7)

Angiotensin (1-7) signals primarily through the Mas receptor. This interaction initiates a cascade involving the phosphoinositide 3-kinase (PI3K)/AKT and extracellular signal-regulated kinase (ERK) pathways. Downstream, this modulates the activity of nitric oxide synthase (increasing NO), transcription factors like FOXO1, and enzymes such as cyclo-oxygenase-2 (COX-2) (Oliveira et al., 2025). These effects translate into anti-fibrotic, anti-inflammatory, and metabolic regulatory actions. The peptide can inhibit the TGF-β-ERK pathway, thereby reducing myofibroblast transition and extracellular matrix deposition. In metabolic tissues, Ang-(1-7) enhances glucose uptake, stimulates lipolysis, and improves insulin sensitivity. Neuroprotective effects are mediated via anti-inflammatory and anti-apoptotic actions, and anti-cancer effects are linked to the inhibition of cell proliferation and angiogenesis (for mechanism review; this article adds validated use conditions).

Evidence & Benchmarks

• In cell-based assays, Angiotensin (1-7) at 100 nM inhibits TGF-β-ERK pathway-mediated myofibroblast transition in NRK-52E rat kidney cells; this effect is reversed by Mas receptor antagonist A779 (Oliveira et al., 2025).
• In vivo, daily intraperitoneal administration of 0.01–0.06 mg/kg Ang-(1-7) in BALB/c mice ameliorates dextran sulfate sodium-induced colitis by reducing phosphorylation of p38, ERK1/2, and Akt (DOI).
• Ang-(1-7) increases glucose uptake and lipolysis in metabolic tissues, improving insulin sensitivity and lowering dyslipidemia (DOI).
• Anti-fibrotic effects are observed in lung, liver, and kidney models, with reduced extracellular matrix deposition and inflammation (see multidimensional role analysis—this article provides direct workflow application parameters).
• Neuroprotective and cognitive benefits include reduced ischemic brain damage and improved memory in preclinical models (DOI).
• Ang-(1-7) has demonstrated anti-cancer actions by inhibiting cell proliferation and angiogenesis in various tumor models (mechanistic insight and strategic vision—this article updates with in vivo benchmarks).

Applications, Limits & Misconceptions

Angiotensin (1-7) is widely utilized in cardiovascular, renal, metabolic, neuroprotective, and oncology research. It is particularly valuable in dissecting anti-fibrotic and anti-inflammatory mechanisms beyond the reach of classical RAS agents. The peptide is also used to study metabolic regulation, insulin sensitivity, and lipid metabolism. Its role in reproductive biology—promoting ovulation, spermatogenesis, and steroid synthesis—broadens its research scope. In addition, Ang-(1-7) has been investigated for its potential to modulate viral entry processes, such as SARS-CoV-2 spike protein binding, but its direct clinical relevance in COVID-19 remains investigational (Oliveira et al., 2025).

Common Pitfalls or Misconceptions

• Angiotensin (1-7) is not a direct substitute for angiotensin II in hypertensive models; it counteracts, not mimics, classical RAS signaling.
• Clinical efficacy in human fibrosis, neuroprotection, or metabolic syndrome is unproven; most data are preclinical.
• The peptide is insoluble in ethanol and must be dissolved in water or DMSO for experimental use (≥48.5 mg/mL in water, ≥89.9 mg/mL in DMSO).
• Long-term solution stability is poor; use only freshly prepared solutions (APExBIO).
• Effects on SARS-CoV-2 spike protein binding are observed in vitro and may not translate to therapeutic benefit (Oliveira et al., 2025).

Workflow Integration & Parameters

For cell-based research, Angiotensin (1-7) is typically applied at 100 nM, as in NRK-52E renal epithelial cells, with endpoints measured after 24–48 hours. For in vivo studies, dosing in mice ranges from 0.01 to 0.06 mg/kg/day via intraperitoneal injection, with efficacy observed in models of inflammation and fibrosis. Product purity from APExBIO exceeds 99.7% (HPLC and mass spectrometry confirmed), supporting reproducible results (for application strategies; this article details mechanistic and dosing benchmarks). Solutions should be freshly prepared and stored at −20°C, desiccated. Control experiments with Mas receptor antagonists (e.g., A779) are recommended to confirm specificity. For comprehensive protocols and troubleshooting, researchers are encouraged to reference the Angiotensin (1-7) product page (SKU A1041).

Conclusion & Outlook

Angiotensin (1-7) is a rigorously validated Mas receptor agonist with demonstrated effects across anti-fibrotic, anti-inflammatory, metabolic, and neuroprotective domains. Its unique mechanism and high-purity commercial availability from APExBIO (SKU A1041) enable reproducible research in diverse preclinical models. While translational promise is robust, clinical efficacy remains to be established. Researchers should observe precise solubility, stability, and workflow controls to maximize experimental fidelity. Further investigation is warranted in viral pathogenesis and cancer, and this article provides actionable reference points for next-generation studies.